Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients.

AIMS The influence of permanent atrial fibrillation on exercise tolerance and cardio-respiratory function during exercise in heart failure (HF) is unknown. METHODS AND RESULTS We retrospectively compared the results of 942 cardiopulmonary exercise tests, performed consecutively at seven Italian laboratories, in HF patients with atrial fibrillation (n = 180) and sinus rhythm (n = 762). By multivariable logistic regression analysis, peak VO(2) (OR 0.376, 95% CI 0.240-0.588, P < 0.0001), O(2)pulse (VO(2)/heart rate, HR) (OR 0.236, 95% CI 0.152-0.366, P < 0.0001), VCO(2) (OR 3.97, 95% CI 2.163-7.287, P < 0.0001), and ventilation (OR 1.38, 95% CI 1.045-1.821, P = 0.0231) were independently associated with atrial fibrillation. Anaerobic threshold (AT) was identified in 132 of 180 (73%) atrial fibrillation and in 649 of 762 (85%) sinus rhythm patients (P = 0.0002). By multivariable logistic regression analysis, only peak VO(2) (OR 0.214, 95% CI 0.155-0.296, P < 0.0001) was independently associated with unidentified AT. At AT, atrial fibrillation HF patients had higher HR (P < 0.0001) and higher VO(2) (P < 0.001) compared with sinus rhythm HF patients. Among AT variables, by multivariable logistic regression analysis, only HR was an independent predictor of atrial fibrillation. CONCLUSION In HF patients with permanent atrial fibrillation, exercise performance is reduced as reflected by reduced peak VO(2). The finding of unidentified AT is associated with a poor performance. In atrial fibrillation patients, VO(2) is higher at AT whereas lower at peak. This last observation raises uncertainties about the use of AT data to define performance and prognosis of HF patients with atrial fibrillation.

[1]  Mary Ann Peberdy,et al.  Development of a Ventilatory Classification System in Patients With Heart Failure , 2007, Circulation.

[2]  A. Curnis,et al.  Atrial fibrillation in heart failure patients: Prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry , 2007, European journal of heart failure.

[3]  D. Reda,et al.  Exercise capacity in atrial fibrillation: a substudy of the Sotalol-Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). , 2007, American heart journal.

[4]  P. Hildebrandt,et al.  Prevalence and prognostic significance of atrial fibrillation in outpatients with heart failure due to left ventricular systolic dysfunction , 2007, European journal of heart failure.

[5]  L. Køber,et al.  Atrial fibrillation, ischaemic heart disease, and the risk of death in patients with heart failure. , 2006, European heart journal.

[6]  D. Mark,et al.  Role of amiodarone or implantable cardioverter/defibrillator in patients with atrial fibrillation and heart failure. , 2006, American heart journal.

[7]  J. Steinberg Desperately seeking a randomized clinical trial of resynchronization therapy for patients with heart failure and atrial fibrillation. , 2006 .

[8]  Catherine Klersy,et al.  Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.

[9]  A. Cohen-Solal,et al.  Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part I: Definition of cardiopulmonary exercise testing parameters for appropriate use in chronic heart failure , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[10]  M. Guazzi,et al.  Endothelial dysfunction and exercise performance in lone atrial fibrillation or associated with hypertension or diabetes: different results with cardioversion. , 2006, American journal of physiology. Heart and circulatory physiology.

[11]  A. Coats,et al.  Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction. Recommendations for performance and interpretation , 2006, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[12]  P. Mitro,et al.  Myocardial Contractility and Cardiac Filling Measured by Impedance Cardiography in Patients with Nitroglycerine‐Induced Vasovagal Syncope , 2006, Pacing and clinical electrophysiology : PACE.

[13]  J. Ornato,et al.  ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .

[14]  K. Wasserman,et al.  Work‐rate affects cardiopulmonary exercise test results in heart failure , 2005, European journal of heart failure.

[15]  Prashanthan Sanders,et al.  Catheter ablation for atrial fibrillation in congestive heart failure. , 2004, The New England journal of medicine.

[16]  J. Murabito,et al.  Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality The Framingham Heart Study , 2003, Circulation.

[17]  W. Maisel,et al.  Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. , 2003, The American journal of cardiology.

[18]  K. Wasserman,et al.  Exercise Anaerobic Threshold and Ventilatory Efficiency Identify Heart Failure Patients for High Risk of Early Death , 2002, Circulation.

[19]  J. E. Hansen,et al.  Ventilatory efficiency during exercise in healthy subjects. , 2002, American journal of respiratory and critical care medicine.

[20]  K. Wasserman,et al.  Non-invasive measurement of stroke volume during exercise in heart failure patients. , 2000, Clinical science.

[21]  A. Coats,et al.  Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2). , 2000, European heart journal.

[22]  J. McMurray,et al.  Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation. , 1999, Circulation.

[23]  M. Brignole,et al.  Assessment of atrioventricular junction ablation and VVIR pacemaker versus pharmacological treatment in patients with heart failure and chronic atrial fibrillation: a randomized, controlled study. , 1998, Circulation.

[24]  R. Fagard,et al.  Atrial fibrillation is associated with a lower exercise capacity in male chronic heart failure patients , 1997, Heart.

[25]  C. Lau,et al.  Oxygen uptake kinetics and cardiopulmonary performance in lone atrial fibrillation and the effects of sotalol. , 1997, Chest.

[26]  H. Crijns,et al.  Long-term effect of cardioversion on peak oxygen consumption in chronic atrial fibrillation. A 2-year follow-up. , 1994, European heart journal.

[27]  K. Wasserman,et al.  Critical capillary oxygen partial pressure and lactate threshold in patients with cardiovascular disease. , 1994, Journal of the American College of Cardiology.

[28]  H. Crijns,et al.  LONG-TERM EFFECT OF CARDIOVERSION ON PEAK OXYGEN-CONSUMPTION IN CHRONIC ATRIAL-FIBRILLATION - A 2 YEARS FOLLOW-UP , 1994 .

[29]  J. Cohn,et al.  The Influence of Atrial Fibrillation on Prognosis in Mild to Moderate Heart Failure The V‐HeFT Studies , 1993, Circulation.

[30]  J R Wilson,et al.  Value of Peak Exercise Oxygen Consumption for Optimal Timing of Cardiac Transplantation in Ambulatory Patients With Heart Failure , 1991, Circulation.

[31]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  B. Whipp,et al.  A new method for detecting anaerobic threshold by gas exchange. , 1986, Journal of applied physiology.